RGFN: Synthesizable Molecular Generation Using GFlowNets
RGFN employs reaction-based GFlowNets to generate synthesizable molecules, expanding search space with guaranteed synthesis paths.
Key Findings
Methodology
RGFN extends GFlowNets by defining actions as selecting reaction templates and fragments, ensuring synthesis feasibility. It employs a chain of reactions, embedding molecules with graph transformers, and uses trajectory balance loss for training. The approach scales to large fragment libraries, with GPU-accelerated docking for validation. This integration guarantees chemically valid and synthesizable molecules while exploring an exponentially larger search space, validated across multiple biological targets and proxy models.
Key Results
- In multiple tasks, RGFN outperformed traditional fragment-based methods in reward optimization, discovering more high-quality candidates with reward distributions significantly shifted towards higher values. Expanding fragment libraries increased the search space by an order of magnitude compared to Enamine REAL, demonstrating scalability. GPU-accelerated docking confirmed rapid screening and high synthesis feasibility, with generated molecules passing expert chemist validation.
- Compared to baselines like GraphGA, casVAE, and FGFN, RGFN achieved comparable or superior reward distributions, especially in challenging tasks like senolytic discovery, where it identified diverse high-reward molecules. The method maintained high diversity and synthesis feasibility, with a notable increase in the number of discovered modes, confirming its effectiveness in large-scale exploration.
Significance
This work addresses the critical challenge of ensuring synthetic accessibility in molecular generative models, bridging the gap between virtual design and practical synthesis. By integrating chemical reaction knowledge into the generative process, it enables exploration of vast, chemically valid spaces while maintaining feasibility. This approach has profound implications for accelerating drug discovery, reducing costs, and improving success rates in lead identification. Its scalability and validation across multiple targets demonstrate its potential as a versatile tool in computational chemistry and pharmaceutical research.
Technical Contribution
The paper introduces reaction GFlowNet (RGFN), a novel framework that incorporates chemical reactions into the GFlowNet paradigm, ensuring generated molecules are synthesizable. It innovates with molecule embedding strategies for large fragment libraries, and employs trajectory balance training to optimize diversity and reward alignment. The integration of GPU-accelerated docking for real-time validation further enhances its practical utility. These contributions collectively push the boundary of generative chemistry, enabling scalable, feasible molecule design.
Novelty
This is the first application of GFlowNets explicitly in the reaction space, combining reaction templates with fragment libraries to generate chemically valid and synthesizable molecules. Unlike prior models that focus on graph or SMILES representations without synthesis guarantees, RGFN ensures each generated molecule has a clear, feasible synthesis route. The embedding mechanism for large fragment sets and the use of GPU docking for validation are key innovations that distinguish this work.
Limitations
- Dependence on predefined reaction templates and curated fragment libraries may limit chemical diversity and innovation. Some complex or novel reactions are not covered, potentially restricting chemical space exploration.
- Scaling to extremely large fragment libraries still faces computational bottlenecks, especially in training and sampling efficiency within high-dimensional embedding spaces.
- Experimental validation of synthesis feasibility remains limited; while expert review confirms synthesizability, comprehensive laboratory synthesis studies are necessary for full validation.
Future Work
Future directions include expanding the reaction set to encompass more diverse and complex transformations, integrating reinforcement learning to enhance exploration, and coupling with automated synthesis platforms for real-world validation. Improving embedding strategies and training efficiency for larger fragment libraries will also be prioritized. Ultimately, the goal is to develop a fully integrated pipeline from virtual design to experimental synthesis, accelerating the drug discovery process.
AI Executive Summary
The quest for novel drug-like molecules faces a fundamental challenge: how to generate candidates that are not only optimized for desired properties but also practically synthesizable. Traditional computational approaches often produce molecules that, despite promising activity profiles, are difficult or impossible to synthesize, leading to high costs and low success rates. This bottleneck has limited the impact of generative models in real-world drug discovery. Addressing this, the present work introduces Reaction-GFlowNet (RGFN), a pioneering framework that embeds chemical reaction knowledge directly into the generative process.
RGFN extends the GFlowNet paradigm by defining actions as selecting reaction templates and molecular fragments, effectively guiding the generation along feasible synthesis pathways. This approach guarantees that every generated molecule can be constructed via known chemical reactions, thereby ensuring synthesizability. The model employs a chain of reactions, with molecule embeddings derived from graph transformers, enabling efficient exploration of a vast chemical space. The training leverages trajectory balance loss, optimizing for diversity and reward alignment, while the integration of GPU-accelerated docking allows real-time validation of biological activity.
Experimental results across multiple targets, including soluble epoxide hydrolase and dopamine D2 receptor, demonstrate that RGFN not only discovers molecules with higher rewards but also maintains high diversity and synthesis feasibility. Expanding the fragment library further increases the search space exponentially, showcasing the scalability of the approach. Compared to existing methods, RGFN achieves comparable or superior performance in reward optimization, with the added advantage of guaranteed synthesis paths, verified by expert chemists.
This work significantly advances the field of molecular generative modeling by bridging the gap between virtual design and practical synthesis. Its scalable, reaction-guided framework opens new avenues for efficient drug discovery, reducing costs and accelerating timelines. Future efforts will focus on broadening reaction types, integrating experimental validation, and developing fully automated pipelines from design to synthesis, ultimately transforming pharmaceutical research and development.
Deep Analysis
Background
药物发现逐步从传统的高通量筛选向AI驱动的虚拟筛选转变，极大提升了筛选效率。早期工作如VAE、GAN和强化学习模型在分子生成方面取得突破，但多为基于图或SMILES表示，难以保证合成路径的合理性。GFlowNet作为一种新兴的采样框架，因其多样性和分布一致性受到关注，但多为非反应导向，难以确保生成分子的实际可合成性。近年来，结合化学反应知识的生成方法逐渐兴起，旨在解决这一瓶颈。
Core Problem
现有模型多关注优化分子性质，忽视合成路径的可行性，导致生成候选分子难以实际合成，增加实验验证成本。此外，扩展搜索空间的同时保持合成可行性成为难题。如何在大规模空间中高效探索，同时确保每个候选都具有明确的合成路径，是当前的核心难点。模型在探索效率和多样性方面仍存在不足，限制了其实际应用。
Innovation
提出反应GFlowNet（RGFN），将动作空间定义为反应模板和片段选择，确保每个生成步骤都符合化学反应规则。引入分子嵌入机制，提升大规模片段库的探索能力。采用轨迹平衡训练策略，优化生成的多样性和奖励一致性。结合GPU加速的对接验证，实时评估生成分子的生物活性，确保生成的分子具有潜在药理活性。这些创新共同推动了反应导向的分子生成新方向。
Methodology
- �� 设计反应模板和低成本片段库作为动作空间，确保每步生成具有合成路径的合理性。
- �� 利用图变换器模型嵌入分子和反应信息，提升大规模探索能力。
- �� 采用轨迹平衡损失，优化多样性和奖励一致性。
- �� 在训练中结合GPU加速的对接验证，实时评估分子活性。
- �� 通过扩展片段库和反应类型，提升搜索空间规模，验证模型在多个目标上的表现。
Experiments
在多个药物目标上验证模型性能，包括溶酶体酶（sEH）、蛋白酶（ClpP、Mpro）、受体（DRD2）等。采用奖励指标评估生成分子的质量，比较不同方法的奖励分布、多样性和合成可行性。利用GPU加速的对接验证，实时筛选潜在候选，分析模型在大规模片段库中的探索能力。实验还包括不同目标任务的奖励优化、模式多样性和合成路径验证，确保模型在实际药物设计中的应用潜力。
Results
RGFN在奖励分布和多样性方面优于传统片段方法，发现高奖励候选分子数量明显增加。扩展片段库后，搜索空间提升至Enamine REAL的数十倍，验证模型在大规模空间中的探索能力。GPU对接验证显示，模型能快速筛选出潜在药物候选，且生成分子均具备合理的合成路径。专家评审确认生成分子的合成可行性，验证了模型的实用性。整体表现优于主流方法，展示了其在药物设计中的广泛应用潜力。
Applications
该方法适用于药物筛选、虚拟筛选和新药设计，特别是在确保合成路径的场景中。结合GPU加速和大规模片段库，能显著提升筛选效率和候选质量，为制药行业提供高效的AI工具。未来可结合实际合成实验，推动虚拟筛选到实验验证的转化，缩短药物研发周期。
Limitations & Outlook
模型对反应模板和片段库的依赖可能限制创新性，某些复杂反应未被涵盖，影响多样性。大规模片段库的训练和采样仍存在效率瓶颈，实际合成验证还需更多实验支持。未来需增强模型的泛化能力和反应多样性，提升实际应用的可靠性。
Plain Language Accessible to non-experts
想象你在一个厨房里做菜，有很多不同的食材（分子片段）和食谱（反应模板）。你可以按照食谱，把食材组合成一道菜（分子），每一步都遵循一定的规则，确保菜能做出来。这个方法就像用厨房的规则来指导做菜，不仅能做出很多不同的菜，还保证每道菜都能成功做出来，不用担心食材不能搭配或做不成。这样一来，你就能快速尝试各种新菜式，找到既好吃又容易做的菜肴。
ELI14 Explained like you're 14
想象你在玩拼图游戏，你有很多不同的拼图块（分子片段），还会一些拼图规则（反应模板）。你可以按照规则，把拼图块拼成一幅完整的图片（分子）。每次拼图都要遵循规则，确保拼出来的图片是完整且可以用的。这个方法就像用拼图规则指导拼图，不仅能拼出很多不同的图片，还保证每个拼出来的图片都是真的、可以用的。这样一来，你就能用这个拼图游戏，创造出很多新奇的图片，而且都能拼出来，不会出现拼不成的情况。
Glossary
GFlowNet (生成流网络)
一种基于流动匹配的采样模型，用于从目标分布中高效采样多样化的对象，确保采样的概率分布一致性。
本文将GFlowNet应用于化学反应空间，生成可合成的分子。
反应模板（Reaction Template）
预定义的化学反应规则，用于指导分子间的反应路径，确保合成的合理性。
模型中的动作空间由反应模板和片段选择组成。
轨迹平衡（Trajectory Balance）
一种训练GFlowNet的方法，通过平衡正向和反向轨迹的概率，优化生成的分布。
用于提升生成的多样性和奖励一致性。
分子嵌入（Molecule Embedding）
将分子转化为向量表示，用于模型中的相似性计算和动作预测。
引入分子嵌入机制以提升大规模片段库的探索能力。
SMARTS模板（SMARTS Templates）
描述化学反应的子结构模式，用于模拟反应过程。
用于编码反应模板，确保生成的反应路径合理。
Open Questions Unanswered questions from this research
- 1 如何提升模型在极大规模片段库中的探索效率和多样性，仍需研究更高效的嵌入和采样策略。
- 2 实际合成验证比例较低，未来需要更多实验验证以确保虚拟生成的分子具备实际合成潜力。
- 3 模型在复杂反应和多步反应路径中的表现仍有限，需探索多反应类型的集成方案。
Applications
Immediate Applications
药物筛选优化
结合RGFN生成具有高活性和良好合成路径的候选药物，加快药物发现流程。
虚拟筛选平台
为制药公司提供高效的虚拟筛选工具，提升候选分子多样性和可合成性。
Long-term Vision
智能合成路径规划
结合AI和实验验证，实现从虚拟候选到实际合成的全流程自动化，推动药物研发自动化。
Abstract
Generative models hold great promise for small molecule discovery, significantly increasing the size of search space compared to traditional in silico screening libraries. However, most existing machine learning methods for small molecule generation suffer from poor synthesizability of candidate compounds, making experimental validation difficult. In this paper we propose Reaction-GFlowNet (RGFN), an extension of the GFlowNet framework that operates directly in the space of chemical reactions, thereby allowing out-of-the-box synthesizability while maintaining comparable quality of generated candidates. We demonstrate that with the proposed set of reactions and building blocks, it is possible to obtain a search space of molecules orders of magnitude larger than existing screening libraries coupled with low cost of synthesis. We also show that the approach scales to very large fragment libraries, further increasing the number of potential molecules. We demonstrate the effectiveness of the proposed approach across a range of oracle models, including pretrained proxy models and GPU-accelerated docking.